Answers are grounded in this paper and cite their sources.
We conclude that patients with liver disease have critically low levels of knowledge of acetaminophen, putting them at risk both of acetaminophen overdose, as well as undermedication, and inadequate management of chronic pain. We recommend an increase in education efforts regarding acetaminophen dosage and its safety in the setting of liver disease. Increasing education for those at risk of low acetaminophen knowledge is essential to minimizing acetaminophen overdose rates and optimizing pain management.
No takes yet. Share an insight, caveat, or question.
Saab et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: